IL-8
IL-8 (interleukin-8, encoded by CXCL8) is a secreted CXC chemokine that attracts and activates neutrophils during inflammation. It is also known as NAP-1, NAF, MDNCF, GCP-1 and LUCT, and is a major mediator of the inflammatory response. Browse Assay Genie's current range of IL-8 research reagents below, or read on for the biology behind the target.
IL-8 is a chemotactic factor that mediates the inflammatory response by attracting neutrophils, basophils and T-cells to clear pathogens and protect the host from infection. It also plays an important role in neutrophil activation. Released in response to an inflammatory stimulus, it acts by binding the G protein-coupled receptors CXCR1 and CXCR2, which are primarily found on neutrophils, monocytes and endothelial cells. A G protein heterotrimer constitutively associates with these receptors; activation by IL-8 releases the beta and gamma subunits from Galpha (GNAI2 in neutrophils) and engages downstream signalling pathways including PI3K and MAPK.
The CXCL8 gene encodes a member of the CXC chemokine family, classed by HGNC among both the chemokine ligands and the interleukins. IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells and fibroblasts, and bacterial and viral products rapidly induce its expression. The gene sits in a cluster with other CXC chemokine genes on chromosome 4q. Earlier names include interleukin 8 and chemokine (C-X-C motif) ligand 8.
Beyond guiding neutrophils to sites of infection, IL-8 participates with other cytokines in proinflammatory signalling and has a role in systemic inflammatory response syndrome. It is believed to contribute to the pathogenesis of bronchiolitis caused by respiratory syncytial virus, and its overproduction is thought to drive the lung inflammation associated with cystic fibrosis. It is also suspected to play a part in coronary artery disease and endothelial dysfunction. Tumour cells secrete IL-8, which promotes tumour migration, invasion, angiogenesis and metastasis. Binding to CXCR2 increases blood vessel permeability, and rising IL-8 levels correlate with greater severity in several disease outcomes, such as sepsis.
IL-8 recruits and activates neutrophils, making it a central readout for studying inflammatory responses and host defence against pathogens.
IL-8 contributes to systemic inflammatory response syndrome, and rising levels correlate with the severity of outcomes such as sepsis.
Secreted by tumour cells, IL-8 promotes migration, invasion, angiogenesis and metastasis, and is a potent angiogenic factor.
IL-8 is implicated in RSV bronchiolitis, cystic fibrosis lung inflammation, coronary artery disease and endothelial dysfunction.
IL-8 is a secreted chemokine that attracts neutrophils, basophils and T-cells to sites of infection and activates neutrophils. It signals through the G protein-coupled receptors CXCR1 and CXCR2, engaging downstream pathways including PI3K and MAPK. It is also a potent angiogenic factor.
Yes. CXCL8 is the HGNC gene symbol for the protein commonly called interleukin-8 or IL-8. Older aliases include SCYB8, NAP-1, NAF, MDNCF, GCP-1, LUCT and LECT, and previous names include interleukin 8 and chemokine (C-X-C motif) ligand 8.
Per the NCBI Gene summary, IL-8 is linked to RSV bronchiolitis, cystic fibrosis lung inflammation, coronary artery disease, endothelial dysfunction and sepsis severity. Tumour cells also secrete it, promoting invasion and metastasis. Check the datasheet of any product for its validated reactivity.
Other CXC chemokines from the same gene cluster and related inflammatory mediators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10145; product specifications from Assay Genie datasheets.